NDC 71335-1653 – Buprenorphine hydrochloride and naloxone hydrochloride dihydrate

Buprenorphine Hydrochloride 2 mg/1; Naloxone Hydrochloride Dihydrate .5 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC71335-1653

Product details

Brand name
Buprenorphine hydrochloride and naloxone hydrochloride dihydrate
Generic name
Buprenorphine hydrochloride and naloxone hydrochloride dihydrate
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA203326
Marketed since
June 27, 2014
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE →

Package NDC codes (1)

Package NDCDescriptionSince
71335-1653-130 TABLET in 1 BOTTLE (71335-1653-1)Oct 29, 2020

Other BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE products